ClassAdvocate.com : Investigation Request

Threshold Pharmaceuticals, Inc. may have misled investors about the clinical trial results of its TH-070 drug, which purported to treat benign prostastic hyperplasia.

Please provide your contact information and details regarding your interest in learning more or joining this investigation:


Name:
Email:
Details:
Residency:
Phone:
No attorney-client relationship exists or should be assumed as a result of this communication. All law firms are required to perform a conflicts check before undertaking any representation. An attorney-client relationship will only be created after you and a law firm expressly agree in writing to the representation.